Vanda Pharmaceuticals
VNDA
#8239
Rank
A$0.44 B
Marketcap
A$7.42
Share price
-3.36%
Change (1 day)
2.79%
Change (1 year)

Earnings for Vanda Pharmaceuticals (VNDA)

Earnings in 2026 (TTM): -A$0.24 Billion

According to Vanda Pharmaceuticals's latest financial reports the company's current earnings are A$0.21 Billion. In 2025 the company made an earning of -A$0.22 Billion a decrease over its 2024 earnings that were of -A$58.23 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Vanda Pharmaceuticals from 2005 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -A$0.24 Billion10.26%
2025 -A$0.22 Billion271.79%
2024 -A$58.23 Million191.43%
2023 -A$19.98 Million-320.45%
2022 A$9.06 M-84.99%
2021 A$60.38 M54.8%
2020 A$39 M19.42%
2019 A$32.66 M4.93%
2018 A$31.12 M-228.6%
2017 -A$24.21 Million-8.98%
2016 -A$26.6 Million-53.79%
2015 -A$57.55 Million-30.18%
2014 -A$82.42 Million173.08%
2013 -A$30.19 Million-25.33%
2012 -A$40.42 Million163.61%
2011 -A$15.34 Million-221.15%
2010 A$12.65 M-124.53%
2009 -A$51.6 Million-29.44%
2008 -A$73.13 Million-36.2%
2007 -A$0.12 Billion21.81%
2006 -A$94.1 Million170.55%
2005 -A$34.78 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
A$37.20 B-16,300.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
A$22.60 B-9,942.61%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
A$15.16 B-6,704.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$44.57 B-19,508.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$18.83 B-8,301.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$13.74 B-6,084.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Titan Pharmaceuticals
TTNP
-A$4.02 Million-98.25%๐Ÿ‡บ๐Ÿ‡ธ USA